Hanna Lesch, Ph.D., Chief Technology Officer

April 21 | 10:30am | Gaudi 2 Ballroom

Nivelles, Belgium


In-Person Presentation

Exothera is a viral vector CDMO using standard and innovative bioproduction platforms to rapidly deliver affordable viral vector-based vaccines and cell and gene therapies. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing and provides QC services and analytical development.


By using this website you agree to accept our Privacy Policy and Terms & Conditions